Drug inhibition and substrate transport mechanisms of human VMAT2. [PDF]
Wei F, Liu H, Zhang W, Wang J, Zhang Y.
europepmc +1 more source
Valbenazine Sprinkle: An Alternative Formulation of Valbenazine for Oral Administration in Patients With Dysphagia. [PDF]
Giri N +8 more
europepmc +1 more source
Methylphenidate as a Novel Adjunct in Opioid-Taking Patients: Insights into Dopaminergic Neuroadaptation and Hypoactive Delirium. [PDF]
Świderski N, Rodek P, Kucia K.
europepmc +1 more source
Environmental noise-induced changes to the IC-SNc circuit promotes motor deficits and neuronal vulnerability in a mouse model of Parkinson's Disease. [PDF]
Cui C +16 more
europepmc +1 more source
Nitrogen waste metabolism as a locus of nitrergic co-transmission in the brain. [PDF]
Bedont JL.
europepmc +1 more source
Placental and fetal consequences of maternal selective serotonin reuptake inhibitor use: current evidence and unresolved questions. [PDF]
Crossen MJ, Hernandez LL.
europepmc +1 more source
Transport pathways across the blood-brain barrier for waste clearance and drug delivery. [PDF]
Gröbner LS, Pietrzik CU.
europepmc +1 more source
Nuclear Medicine Imaging Biomarkers in Parkinson's Disease: Past, Present, and Future Directions. [PDF]
Martini AL +3 more
europepmc +1 more source
Osmotin-derived 9-amino-acid peptide alleviates α-synuclein and MPTP-induced glial cell activation mediated neuroinflammation, protecting dopaminergic neurons in Parkinson's disease mice brain. [PDF]
Choe K +6 more
europepmc +1 more source

